Xarelto Lawsuit Plaintiff Claims Once Daily Dose Is Ineffective

TheProductLawyers.com reports on a new lawsuit filed on October 8, 2015, by a plaintiff claiming the dosage requirement for Xarelto is ineffective and directly precipitated his stroke which he was susceptible to having due to his atrial fibrillation, a very common heart condition. The plaintiff states in his court filing that he suffered a stroke, which the drug was being used to prevent, a mere 4 days after he started his treatment.

Most blood-thinning drugs require a patient take 2 pills a day to keep the drug in their system for a 24-hour period in order to effectively do what it is designed for. Xarelto is in a league by itself since it is the only blood-thinning drug with a once daily regimen and has been called into question, as it is advertised as a "one-size-fits-all" solution not accounting for a patient's differing size or weight.

The plaintiff, in this particular case, is suing the manufacturers, Janssen Pharmaceuticals, a subdivision of the Johnson and Johnson Corporation, and Bayer AG, claiming the once daily dosage is ineffective.

This case is a departure from the lawsuits filed before it since it is the first to dispute the dosage requirements. The two consolidated groups of lawsuits all focused on the dangerous risks associated with alleged excessive bleeding that many patients experienced and many died from. There are two groups of cases that precede the October 2015 filing that encompass 550+ in a mass tort program in Philadelphia, PA as well as the second group in a multidistrict litigation (MDL 2592) with 2,800+ cases being overseen by a court in Eastern Louisiana.

It should be noted too that the controversy over Xarelto does not stop in the courtroom. The FDA, since its initial approval, has issued two ominous black box warnings usually indicating that a product may soon be removed from the consumer market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.